Literature DB >> 31954196

Tear cytokine levels in the diagnosis and severity assessment of ocular chronic graft-versus-host disease(GVHD).

Bohao Hu1, Yuan Qiu1, Jing Hong2.   

Abstract

PURPOSE: To analyse the tear cytokine levels of patients diagnosed with ocular chronic graft-versus-host disease(GVHD)and examine the consistency of these levels with different ocular surface parameters.
METHODS: 23 ocular chronic GVHD patients were selected for the assessment of tear cytokine levels and ocular surface parameters (TBUT, CFS, OSDI, and Schirmer's test), and 16 dry eye disease(DED)patients without systemic immune disease were selected as the control group. The 23 cytokines were measured using microsphere-based immunoassay analysis and their consistency with different ocular surface parameters was studied.
RESULTS: ICAM-1, IL-1β, IL-6, and IL-8 showed elevated levels in the eyes of oGVHD patients compared to DED [P < 0.001]. IL-7 and EGF showed lower levels in the eyes of patients with oGVHD than in those of patients with DED [P < 0.0001]. Furthermore, the levels of IL-6 and IL-8 showed a stronger correlation with corneal fluorescein staining (CFS) (P < 0.05), and the levels of IL-6 and ICAM-1 were most consistent with fluorescein tear film break-up time (TBUT) (P < 0.05).
CONCLUSIONS: Our study demonstrated certain tear cytokines, including ICAM-1, IL-1β, IL-6, IL-8 IL-7 and EGF, as promising new possible diagnostic markers of chronic oGVHD and criteria for chronic ocular GVHD severity. Because tear sampling is noninvasive and simple, this method is expected to be an overwhelming applicable for the screening and diagnosis of chronic GVHD.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Ocular graft versus host disease dry eye disease; Tear cytokines

Mesh:

Substances:

Year:  2020        PMID: 31954196     DOI: 10.1016/j.jtos.2019.12.005

Source DB:  PubMed          Journal:  Ocul Surf        ISSN: 1542-0124            Impact factor:   5.033


  5 in total

Review 1.  Update on ocular graft-versus-host disease.

Authors:  Sridevi Nair; Murugesan Vanathi; Ritika Mukhija; Radhika Tandon; Sandeep Jain; Yoko Ogawa
Journal:  Indian J Ophthalmol       Date:  2021-05       Impact factor: 1.848

2.  Ophthalmic manifestations are associated with reduced tear lymphotoxin-α levels in chronic ocular graft-versus-host disease.

Authors:  Jiao Ma; Chendi Li; Yinghan Zhao; Zhan Shen; Bohao Hu; Rongmei Peng; Jing Hong
Journal:  BMC Ophthalmol       Date:  2022-01-10       Impact factor: 2.209

3.  Ocular Surface Inflammatory Disorders (OSID): A Collective of Systemic Etiologies Which Cause or Amplify Dry Eye Syndrome.

Authors:  Matias Soifer; Nadim S Azar; Hazem M Mousa; Victor L Perez
Journal:  Front Med (Lausanne)       Date:  2022-07-06

Review 4.  Cascade of Inflammatory, Fibrotic Processes, and Stress-Induced Senescence in Chronic GVHD-Related Dry Eye Disease.

Authors:  Yoko Ogawa; Yutaka Kawakami; Kazuo Tsubota
Journal:  Int J Mol Sci       Date:  2021-06-06       Impact factor: 5.923

5.  National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2020 Highly morbid forms report.

Authors:  Daniel Wolff; Vedran Radojcic; Robert Lafyatis; Resat Cinar; Rachel K Rosenstein; Edward W Cowen; Guang-Shing Cheng; Ajay Sheshadri; Anne Bergeron; Kirsten M Williams; Jamie L Todd; Takanori Teshima; Geoffrey D E Cuvelier; Ernst Holler; Shannon R McCurdy; Robert R Jenq; Alan M Hanash; David Jacobsohn; Bianca D Santomasso; Sandeep Jain; Yoko Ogawa; Philipp Steven; Zhonghui Katie Luo; Tina Dietrich-Ntoukas; Daniel Saban; Ervina Bilic; Olaf Penack; Linda M Griffith; Meredith Cowden; Paul J Martin; Hildegard T Greinix; Stefanie Sarantopoulos; Gerard Socie; Bruce R Blazar; Joseph Pidala; Carrie L Kitko; Daniel R Couriel; Corey Cutler; Kirk R Schultz; Steven Z Pavletic; Stephanie J Lee; Sophie Paczesny
Journal:  Transplant Cell Ther       Date:  2021-06-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.